Bernhard Günther is President of Novaliq Inc. He founded Novaliq GmbH in 2007 and was Chief Executive Officer until October 2016. He has more than 25 years of professional experience in the field of ophthalmic medical devices and biopharmaceuticals.
Prior to Novaliq, Mr. Günther served as Chief Executive Officer of Fluoron GmbH, a German medical device company, which pioneered the development of proprietary ophthalmic Biomaterials for the treatment of severe retinal diseases.
During his tenure at Fluoron, Mr. Günther transformed the company into an internationally leading manufacturer of highly innovative vitreous substitutes and intraocular staining solutions.
Mr. Günther further serves as a supervisory board member of Geuder AG and holds a Diploma in Polymer Engineering from the University of Applied Sciences in Darmstadt.